Huadong Medicine

Huadong Medicine Pvt Ltd
SZSE: 000963
IndustryPharmaceuticals
Founded1993
HeadquartersHangzhou, China
Websitewww.eastchinapharm.com

HD Medicine, or Huadong Medicine Co., Ltd., is a Hangzhou-based pharmaceutical company registered on the Shenzhen Stock Exchange since December 1999. It has a listed share capital of 380,000,000 RMB and a market capitalization of 5.1981 billion RMB as of June 2026[1]. It is the largest pharmaceutical company in Zhejiang and the leading immunosuppressant manufacturer in China.[2]

In June 2025, the company received approval to commence clinical trials for Roflumilast Foam, targeting dermatological conditions. [3]

References

  1. ↑ "Huadong Medicine Market Capital". 2026-06-22. Retrieved 2026-06-22.
  2. ↑ China Listed Companies Handbook (Vol 4). Javvin Technologies. 2008. p. 69. ISBN 978-1-60267-023-5.
  3. ↑ Newswires, M. T. (2025-06-11). "Huadong Medicine Gets Clinical Trial Approval for Roflumilast Foam | MarketScreener". www.marketscreener.com. Retrieved 2025-06-26.


This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.